MedImpact Expands Access to Two Biosimilars for Stelara
Pharmacy- and manufacturer-neutral approach offers members access to therapeutically equivalent, lower cost alternativesSAN DIEGO--(BUSINESS WIRE)--MedImpact Healthcare Systems, the nation’s largest ...
Managed Healthcare Executive20m
FDA Accepts BLA Resubmission for Follicular Lymphoma Drug, Odronextamab
The FDA has accepted the biologics licensing application (BLA) resubmission for odronextamab, a potential treatment for ...
Managed Healthcare Executive1h
Congress Turns Attention to PBM Reform, Sort of
At what was supposed to be a hearing to discuss PBM reform, some in Congress veered off into discussions about Medicaid and ...